Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Naoko Hosono"'
Publikováno v:
HemaSphere, Vol 7, p e6714808 (2023)
Externí odkaz:
https://doaj.org/article/6e4c0ac7d0824c16a2c8ab3473fec9e6
Autor:
Alexander E. Perl, Naoko Hosono, Pau Montesinos, Nikolai Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C. Smith, Mark J. Levis, Stephen Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je-Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V. Tiu, Jessica K. Altman
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-9 (2022)
Abstract The fms-like tyrosine kinase 3 (FLT3) inhibitor gilteritinib is indicated for relapsed or refractory (R/R) FLT3-mutated acute myeloid leukemia (AML), based on its observed superior response and survival outcomes compared with salvage chemoth
Externí odkaz:
https://doaj.org/article/177517e470014866a24e2133dc705fd7
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Pralatrexate (PDX) is a novel antifolate approved for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma, but some patients exhibit intrinsic resistance or develop acquired resistance. Here, we evaluated
Externí odkaz:
https://doaj.org/article/505495238d0e4a3cb8ed7d4fcdd6d823
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Cytarabine (ara-C) is the major drug for the treatment of acute myeloid leukemia (AML), but cellular resistance to ara-C is a major obstacle to therapeutic success. The present study examined enhanced anti-apoptosis identified in
Externí odkaz:
https://doaj.org/article/7266c6414a0c43f49498699e619043bb
Autor:
Tetsuya Tsujikawa, Toshiki Tasaki, Naoko Hosono, Tetsuya Mori, Akira Makino, Yasushi Kiyono, Paolo Zanotti-Fregonara, Takahiro Yamauchi, Hidehiko Okazawa
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-9 (2019)
Abstract Background Bone marrow failure syndrome (BMFS) is a heterogeneous group of disorders associated with single- or multiple-lineage cytopenia and failure of normal hematopoiesis. We assessed the feasibility of integrated PET/MRI with 3′-deoxy
Externí odkaz:
https://doaj.org/article/ea9980fdc2114f0baae8b655ca15eef0
Autor:
Seiichiro Katagiri, SungGi Chi, Yosuke Minami, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Takanobu Morishita, Takeshi Kondo, Masamitsu Yanada, Kazuhito Yamamoto, Junya Kuroda, Kensuke Usuki, Daigo Akahane, Akihiko Gotoh
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4694 (2022)
KIT is a type-III receptor tyrosine kinase that contributes to cell signaling in various cells. Since KIT is activated by overexpression or mutation and plays an important role in the development of some cancers, such as gastrointestinal stromal tumo
Externí odkaz:
https://doaj.org/article/ced5a4a6428e42ab866905aa9f50e894
Autor:
Dayong Huang, Yasunobu Nagata, Vera Grossmann, Tomas Radivoyevitch, Yusuke Okuno, Genta Nagae, Naoko Hosono, Susanne Schnittger, Masashi Sanada, Bartlomiej Przychodzen, Ayana Kon, Chantana Polprasert, Wenyi Shen, Michael J. Clemente, James G. Phillips, Tamara Alpermann, Kenichi Yoshida, Niroshan Nadarajah, Mikkael A. Sekeres, Kevin Oakley, Nhu Nguyen, Yuichi Shiraishi, Yusuke Shiozawa, Kenichi Chiba, Hiroko Tanaka, H. Phillip Koeffler, Hans-Ulrich Klein, Martin Dugas, Hiroyuki Aburatani, Satoru Miyano, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Yang Du, Seishi Ogawa, Hideki Makishima
Publikováno v:
Haematologica, Vol 100, Iss 8 (2015)
Next generation sequencing technologies have provided insights into the molecular heterogeneity of various myeloid neoplasms, revealing previously unknown somatic genetic events. In our cohort of 1444 cases analyzed by next generation sequencing, som
Externí odkaz:
https://doaj.org/article/7b2ba56a239a4ef6adde001ebcf46b0c
Autor:
Takayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, Naoko Hosono, Yasuyoshi Morita, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, Keisuke Matsubara, Saori Sugimoto, Yasushi Miyazaki, Masahiro Kizaki, Koichi Akashi
Publikováno v:
Cancer Science. 113:4258-4266
Therapeutic improvements are needed for patients with acute myeloid leukemia (AML), particularly those who have relapsed or who have treatment-refractory (R/R) AML or newly diagnosed patients with poor prognostic factors. Alvocidib (DSP-2033), a pote
Autor:
Toshiki, Tasaki, Tetsuya, Tsujikawa, Naoko, Hosono, Tetsuya, Mori, Akira, Makino, Yasushi, Kiyono, Hidehiko, Okazawa, Takahiro, Yamauchi
Publikováno v:
Clinical Nuclear Medicine. 47:1048-1055
Peripheral cytopenias are typical of blood test abnormalities associated with a variety of conditions, including aplastic anemia (AA) and myelodysplastic syndromes (MDSs). We prospectively investigated the feasibility of quantitative analysis of whol
Autor:
Hiroaki Araie, Toshiki Tasaki, Naoko Hosono, Tetsuya Tsujikawa, Hidehiko Okazawa, Takahiro Yamauchi
Publikováno v:
Annals of Hematology.